
COO/CFO/Treasurer @OpenMedF | Funding outcome-driven research and changing the global landscape for chronic complex diseases: https://teapawt.net/t.co/3C3mNtIjHk | #mecfs #longcovid
- Tweets456
- Following3K
- Followers789
- Likes3.3K

ALT Title: RTHM introduces a new health intelligence platform! -Get a personalized roadmap with next steps for treatments and labs -Organize all your health history in one HIPAA- compliant place -Stay updated on the latest IACC research -Access HIPAA-compliant AI 24/7 -Free to use Image of a cell phone on the right with a screen of the new intelligence platform Arrow at the bottom to swipe to the next slide

ALT The image is a graphic for StudyME, highlighting a celebration of over 11,600 sign-ups. It features a colorful and festive background with confetti and people raising their hands in celebration. The text encourages to learn about 8 Reasons to Sign Up for OMF’s StudyME Registry!

ALT The image contains four informational cards about the benefits of StudyME for ME/CFS research. Faster Research: StudyME facilitates easier recruitment of participants, speeding up publication of findings. Higher Quality Research: It helps researchers find ideal participants, leading to higher quality and more replicable findings. Increased Awareness: Annual surveys can highlight various challenges of living with ME/CFS, raising awareness. Expanded Funding: Demonstrating a willing patient community helps researchers secure more funding for studies.

ALT The image features four informational cards about the advantages of StudyME for ME/CFS research. More Collaboration: StudyME encourages global collaboration among ME/CFS researchers, leading to better insights. Reduced Failure Rate: It improves sample sizes for research, reducing the likelihood of studies being dismissed due to low sample sizes. Increased Credibility: StudyME can set the standard for recruiting high-quality participants, boosting confidence among government and pharma entities to invest in ME/CFS research. Stronger Community: It bridges the gap between researchers and patients, fostering collaboration and mutual learning.
























